SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044018
Filing Date
2021-08-12
Accepted
2021-08-12 16:37:32
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-10q_20210630.htm   iXBRL 10-Q 2491412
2 EX-10.1 nktx-ex101_6.htm EX-10.1 493387
3 EX-31.1 nktx-ex311_12.htm EX-31.1 18604
4 EX-31.2 nktx-ex312_11.htm EX-31.2 17932
5 EX-32 nktx-ex321_7.htm EX-32.1 14920
  Complete submission text file 0001564590-21-044018.txt   7907764

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nktx-20210630.xsd EX-101.SCH 38653
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktx-20210630_cal.xml EX-101.CAL 47479
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktx-20210630_def.xml EX-101.DEF 116036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20210630_lab.xml EX-101.LAB 332104
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20210630_pre.xml EX-101.PRE 243064
11 EXTRACTED XBRL INSTANCE DOCUMENT nktx-10q_20210630_htm.xml XML 1292016
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 211168212
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences